# Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System

> **NCT02690805** · — · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 16 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** MR-compatible scinti-mammography (MRI-SMM) system

## Key facts

- **NCT ID:** NCT02690805
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2019-01-25
- **Final completion:** 2019-01-25
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2021-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02690805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02690805, "Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02690805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*